Drugs and Devices

FDA approves Marqibo for rare type of leukemia

On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares